This federal contract award, with a ceiling value of $1,270,437.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the provision of Adenovirus Type 4 vaccines, which support military immunization programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Teva with the DLA, valued at $5,687,207.30, to serve as the national prime vendor for Levalbuterol HCL Solution. Additionally, Teva holds several other significant IDCs with the Department of Veterans Affairs (VA), including a $64,352,514.80 contract for glatiramer acetate injections and a $109,085,460 contract for Albuterol HFA inhalers. These long-term, high-value IDCs highlight Teva's critical role in supplying essential medications to various federal healthcare programs. The contract does not have a set-aside designation, as Teva competes as a large business in unrestricted solicitations.
Generated 12/18/24, 9:02 AM